Master the Skills Needed to Overcome the Challenges of Modern Paragraph IV Litigation
As the industry prepares to address the fallout of global pharmaceutical patent losses of billions of dollars and the impact of evolving law, regulation and policy impacting the Hatch-Waxman landscape, the time for this conference has never been more relevant.
Learn from preeminent patent litigators representing brand name and generic drug makers as they provide key insights on:
- Pending Hatch-Waxman reform measures which may impact your practice and change the balance of power between brand names and generics
- The impact of new Section 101 and 112 challenges on ANDA litigation
- Evolving Doctrine of Equivalents jurisprudence and how it is affecting Hatch-Waxman cases
- Novel and strategic use of 12(b) and 12 (c) motions
- The application of blocking patents post-Acorda
- New developments impacting parallel proceedings
- The economic impact of recent FDA activity affecting market access and exclusivities
Download The Complete Agenda and Faculty List Now!
Sign up and stay tuned for more exciting announcement about Paragraph IV Disputes Symposium and our incredible speaker line-up!
Get judicial insights on the complex challenges facing both brand name and generic drug manufacturers:
United States District Court
Honorable Rebecca R. Pallmeyer
Northern District of Illinois
Honorable Tonianne Bongiovanni
District of New Jersey
Honorable Roy Payne
Eastern District of Texas
Honorable Sidney I. Schenkier
Northern District of Illinois
United States Patent and Trademark Office, Patent Trial and Appeal Board
Honorable Jacqueline Wright Bonilla
Vice Chief Administrative Patent Judge
Honorable Michelle N. Ankenbrand
Lead Administrative Patent Judge
Honorable Rama G. Elluru
Administrative Patent Judge
Don’t miss SPOTLIGHT ON PHARMACEUTICAL ANTITRUST IN AMERICA from the FTC
Federal Trade Commission (Washington, DC)
A few words from our Co-Chairs:
Ryan M. Daniel
Acting Chief Patent Counsel
Fresenius Kabi USA, LLC
“I’m excited to participate in ACI’s 2019 Paragraph IV Conference here in Chicago. It’s a welcome opportunity to engage with colleagues regarding the evolving landscape of Hatch-Waxman law and the pharmaceutical industry.”
Associate General Counsel, IP Litigation
“ACI’s Paragraph IV Conference series offers a great opportunity to convene and exchange ideas with subject matter experts from all over the country. I am delighted to return to Chicago and to meet with our many talented Hatch-Waxman litigators and colleagues in the industry.”
Who you will meet:
Patent attorneys and litigators (in-house & law firms) who represent:
- Brand name pharmaceutical companies
- Generic pharmaceutical companies
- Biopharmaceutical companies
Wednesday, October 2, 2019
The Hatch-Waxman Series Advisory Board on “The Three C’s”: An Intimate Discussion on the Expectations of In-House Counsel from Their Law Firm Partners
9:00am – 12:00pm
Working Group on Biosimilars for the Hatch-Waxman Litigator
1:00pm – 4:30pm
Register with the All Access Pass to include both workshops and save!
Best rates expire soon
Reserve your seat today by calling 888-224-2480 or register online.
Save On Your Stay
W Chicago – City Center
172 West Adams Street, Chicago, IL 60603
The American Conference Institute is pleased to offer our delegates a negotiated rate for hotel rooms at the W Chicago – City Center. To take advantage of these rates, please contact the hotel directly on or before Saturday, August 31, 2019 and quote "ACI's Paragraph IV Conference".
Please note that guestroom rate is subject to availability.